<DOC>
	<DOC>NCT01102205</DOC>
	<brief_summary>Oxidative stress leads to or accompanies with numerous disease. Oxidative balance in subclinical hypothyroid or euthyroid state in Hashimoto disease are not known. Effect of levothyroxine therapy on oxidative balance are also not known in hashimoto disease.</brief_summary>
	<brief_title>Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease</brief_title>
	<detailed_description>oxidative stress markers will be measured initially(TAS,TOS,OSI,PARAOXONASE,ARYLESTERASA,PON1 PHENOTYPİNG,LİPİDPEROXİD).After 3 months therapy with levothyroxine measurements will be repeated except PON1 phenotyping.</detailed_description>
	<mesh_term>Hashimoto Disease</mesh_term>
	<criteria>age more than 18 years inability to give a written consent other conditions and drug usage affect oxidative stress</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>